Testing For Hereditary Diseases: Genetic Compatibility Test (GCT)

By MD, MSc (gynecologist), BSc, MSc (embryologist) and (invitra staff).
Last Update: 12/13/2019

The genetic compatibility test (GCT) is a test that minimizes the transmission of genetic diseases to offspring, since it is able to identify the altered genes in each member of the couple and detect if there is any mutation in common.

In concrete, GCT can prevent the transmission of some 600 genetic diseases, which do not have a definitive cure at present.

For this reason, it is interesting to know a priori the possible mutations that go unnoticed in the person and, in the case of sharing the same mutation with the couple, to know what actions to take at the moment of considering a pregnancy.

What is a recessive genetic disease?

A recessive inherited genetic disease is one in which both copies of the causative gene must be altered for the disease to manifest.

The affected person has inherited a defective copy of the gene from the mother and another from the father. On the other hand, the parents are only healthy carriers of the pathology, with no symptoms or effect on their person.

It should be noted that a large part of the population carries genetic mutations, which can be passed from generation to generation without being aware of it. Only if you connect to another person with the same mutation can the disease come to light when you have a child.

The chance that a child will inherit a recessive genetic disease if both parents have a common mutation is 25%. On the other hand, the probability of only being a carrier of the disease will be 50% and, if totally healthy, 25%.

You can learn more about the inheritance of genetic diseases in detail in the following article: What are monogenic diseases?

Genetic compatibility test

Today, genetic diseases do not have a definitive cure. However, they can be prevented by a genetic compatibility test, also called carrier study or genetic matching.

Gynecologist Valeria Sotelo comments that:

About 7,000 genetic diseases are known today, and 1 in every 100 births may suffer from one of these diseases.

In the next section, we are going to comment some interesting aspects of the GCT.

Indications

In general, any couple can have a genetic match test to find out what mutations are present in their genetic material, even if there is no family history of any pathology.

As we have said before, about 7,000 genetic diseases are known today, of which 56% of the population is a carrier.

However, it is most common to do a carrier study in the following situations:

Before an assisted reproductive treatment
more and more fertility clinics are recommending this study in order to better determine the most appropriate treatment. In addition, it is important to do so in couples with a history of a genetic disease or if one of them already knows it is a carrier.
Before treatment with gametes donation
GCT allows a better selection of the sperm donor or egg donor, so that they do not share the same mutations with the recipients. Today, most clinics guarantee the performance of GCT to all their candidates for gametes donation.
Consanguineous Couples
GCT is highly recommended when couples are related in some way, especially in "closed" ethnic groups or isolated geographic areas.

How is the GCT performed?

As we have already mentioned, genetic compatibility analysis consists of determining a person's altered genes and analysing them together with those of their partner to study the probability that their child will inherit a serious genetic disease.

In order to do this, it is simply necessary to draw blood from each of the parents and analyse the DNA using different genetic techniques.

The results of this genetic compatibility study usually take about 30 days, although this depends on the techniques used in the laboratory. Some clinics claim to have results in 2 or 3 weeks at the most.

GCT is capable of analyzing about 550 genes, in which it can detect up to 4,500 mutations linked to more than 600 recessive genetic diseases.

The most common monogenic recessive diseases in the population are: cystic fibrosis, spinal muscular atrophy, hemophilia, fragile X syndrome, thalassemines, etc.

Thanks to the genetic compatibility test, it is possible to reduce the risk of having a baby affected by one of these diseases from 1% to less than 0.01%.

Prevention of inherited diseases

If the GCT results show that there is no common genetic mutation in both partners, they can seek pregnancy with the peace of mind that their children will not inherit the recessive diseases included in the study.

If, however, the same mutation responsible for some genetic pathology is detected in both parents, the risk of having a baby affected by this disease is 25%.

In this case, it will be necessary to take all necessary measures to avoid transmitting the hereditary disease to the offspring. The most common are the following:

Preimplantation genetic diagnosis (PGD)
although a couple does not have infertility problems, the presence of a recessive mutation in both parents is an indication for in vitro fertilization (IVF) with PGD. With this test performed on embryos, it is possible to select only those that are genetically healthy to transfer them to the mother's womb and discard the rest.
Gametes donation
is another possible option to avoid transmitting a genetic disease, bet it sperm donation or egg donation. Generally, gametes donors are also subjected to this genetic test, so we will study their compatibility with that of carrier patients.

In short, the genetic compatibility test is very useful to avoid or prevent the emergence of numerous recessive diseases that today have no cure.

FAQs from users

What if I find out I'm a carrier of a genetic mutation?

By Zaira Salvador BSc, MSc (embryologist).

Presenting a recessive genetic mutation does not pose any health risk and the disease will not develop. We are all carriers of numerous recessive genetic mutations. However, this type of mutation can go unnoticed for generations, unless two people carrying the same mutation are paired and a sick baby is born as a result of this union.

How important is the genetic compatibility test?

By Zaira Salvador BSc, MSc (embryologist).

The main advantage of the genetic compatibility test is that it prevents the birth of sick children. For this reason, it is very important to detect which couples are carriers of a specific mutation that can be inherited by their offspring.

How much does the genetic compatibility test cost?

By Zaira Salvador BSc, MSc (embryologist).

The genetic compatibility test may range from $100 up to $2000, depending on each type and complexity of the test and whether more than one test is necessary.

When a test is recommended by your doctor, your health care provider may take over the costs of the GCT.

Suggested for you

PGD is the most important diagnostic test for preventing the transmission of a genetic disease to offspring. If you want to know all the details about this, you can read more here: What Is PGD or Preimplantation Genetic Diagnosis?

If you are already pregnant and want to know if the baby you are expecting is totally healthy, the indicated prenatal test is amniocentesis. You can find out what the following link consists of: What is amniocentesis?

Our editors have made great efforts to create this content for you. By sharing this post, you are helping us to keep ourselves motivated to work even harder.

References

Authors and contributors

 Valeria Sotelo
Valeria Sotelo
MD, MSc
Gynecologist
Bachelor's Degree in Medicine from the University of Buenos Aires. Specialist in Gynecology & Obstetrics. Master's Degree in Video-laparoscopic Surgery, and Certificate of Specialist in Gynecology. Associate Member of the Spanish Fertility Society (SEF) and the Spanish Society of Gynecology & Obstetrics. More than 10 years of experience in the field of Reproductive Medicine. More information about Valeria Sotelo
License: 030309166
 Zaira Salvador
Zaira Salvador
BSc, MSc
Embryologist
Bachelor's Degree in Biotechnology from the Technical University of Valencia (UPV). Biotechnology Degree from the National University of Ireland en Galway (NUIG) and embryologist specializing in Assisted Reproduction, with a Master's Degree in Biotechnology of Human Reproduction from the University of Valencia (UV) and the Valencian Infertility Institute (IVI) More information about Zaira Salvador
License: 3185-CV
Adapted into english by:
 Romina Packan
Romina Packan
inviTRA Staff
Editor and translator for the English and German edition of inviTRA. More information about Romina Packan

Find the latest news on assisted reproduction in our channels.